BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15880256)

  • 1. Structural features and molecular evolution of Bowman-Birk protease inhibitors and their potential application.
    Qi RF; Song ZW; Chi CW
    Acta Biochim Biophys Sin (Shanghai); 2005 May; 37(5):283-92. PubMed ID: 15880256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of a 16 kDa double-headed Bowman-Birk trypsin inhibitor from barley seeds at 1.9 A resolution.
    Song HK; Kim YS; Yang JK; Moon J; Lee JY; Suh SW
    J Mol Biol; 1999 Nov; 293(5):1133-44. PubMed ID: 10547291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the amino acid sequences of plant Bowman-Birk inhibitors.
    Prakash B; Selvaraj S; Murthy MR; Sreerama YN; Rao DR; Gowda LR
    J Mol Evol; 1996 May; 42(5):560-9. PubMed ID: 8662008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absolute structural requirement for a proline in the P3'-position of Bowman-Birk protease inhibitors is surmounted in the minimized SFTI-1 scaffold.
    Daly NL; Chen YK; Foley FM; Bansal PS; Bharathi R; Clark RJ; Sommerhoff CP; Craik DJ
    J Biol Chem; 2006 Aug; 281(33):23668-75. PubMed ID: 16766795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the Bowman-Birk inhibitor from barley seeds in ternary complex with porcine trypsin.
    Park EY; Kim JA; Kim HW; Kim YS; Song HK
    J Mol Biol; 2004 Oct; 343(1):173-86. PubMed ID: 15381428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide mimics of the Bowman-Birk inhibitor reactive site loop.
    McBride JD; Watson EM; Brauer AB; Jaulent AM; Leatherbarrow RJ
    Biopolymers; 2002; 66(2):79-92. PubMed ID: 12325158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory properties and solution structure of a potent Bowman-Birk protease inhibitor from lentil (Lens culinaris, L) seeds.
    Ragg EM; Galbusera V; Scarafoni A; Negri A; Tedeschi G; Consonni A; Sessa F; Duranti M
    FEBS J; 2006 Sep; 273(17):4024-39. PubMed ID: 16889634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors.
    Weder JK; Hinkers SC
    J Agric Food Chem; 2004 Jun; 52(13):4219-26. PubMed ID: 15212472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
    Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
    J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of protease inhibitors based on the Bowman-Birk reactive site loop to hydrolysis by proteases.
    Gariani T; Leatherbarrow RJ
    J Pept Res; 1997 Jun; 49(6):467-75. PubMed ID: 9266473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conserved P1' Ser of Bowman-Birk-type proteinase inhibitors is not essential for the integrity of the reactive site loop.
    Brauer AB; Leatherbarrow RJ
    Biochem Biophys Res Commun; 2003 Aug; 308(2):300-5. PubMed ID: 12901868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular evolution of Bowman-Birk type proteinase inhibitors in flowering plants.
    Mello MO; Tanaka AS; Silva-Filho MC
    Mol Phylogenet Evol; 2003 Apr; 27(1):103-12. PubMed ID: 12679075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo sequencing and characterization of a novel Bowman-Birk inhibitor from Lathyrus sativus L. seeds by electrospray mass spectrometry.
    Tamburino R; Severino V; Sandomenico A; Ruvo M; Parente A; Chambery A; Di Maro A
    Mol Biosyst; 2012 Oct; 8(12):3232-41. PubMed ID: 23064155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and analysis of novel bicyclic and bifunctional protease inhibitors.
    Jaulent AM; Leatherbarrow RJ
    Protein Eng Des Sel; 2004 Sep; 17(9):681-7. PubMed ID: 15486024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic peptide mimics of the Bowman-Birk inhibitor protein.
    McBride JD; Leatherbarrow RJ
    Curr Med Chem; 2001 Jul; 8(8):909-17. PubMed ID: 11375759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small peptides derived from the Lys active fragment of the mung bean trypsin inhibitor are fully active against trypsin.
    Qi RF; Liu ZX; Xu SQ; Zhang L; Shao XX; Chi CW
    FEBS J; 2010 Jan; 277(1):224-32. PubMed ID: 19954491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological significance of polymorphism in legume protease inhibitors from the Bowman-Birk family.
    Clementea A; Domoney C
    Curr Protein Pept Sci; 2006 Jun; 7(3):201-16. PubMed ID: 16787260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bowman-Birk protease inhibitor from the seeds of Vigna unguiculata forms a highly stable dimeric structure.
    Rao KN; Suresh CG
    Biochim Biophys Acta; 2007 Oct; 1774(10):1264-73. PubMed ID: 17869196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conserved cis peptide bond is necessary for the activity of Bowman-Birk inhibitor protein.
    Brauer AB; Domingo GJ; Cooke RM; Matthews SJ; Leatherbarrow RJ
    Biochemistry; 2002 Aug; 41(34):10608-15. PubMed ID: 12186545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary structure of Dioclea glabra trypsin inhibitor, DgTI, a Bowman-Birk inhibitor.
    Bueno NR; Fritz H; Auerswald EA; Mentele R; Sampaio M; Sampaio CA; Oliva ML
    Biochem Biophys Res Commun; 1999 Aug; 261(3):838-43. PubMed ID: 10441512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.